rs
05
utical Business Segment-Specialty Chemicals Manufacturing Facilities Core sustainability pillars 05 Industry Overview 06 Way Forward Overview on Pharmaceutical Sector Future growth prospects O
35%
17 Largest producer of Ibuprofen and the only company worldwide being backward integrated with ~35% Global share Spread over a sprawling campus of over 111 acres Key Highlights Largest produc
30%
Zero Discharge Effluent Treatment Plant 2nd Largest producer of Iso Butyl Benzene (IBB) with ~30% Global share Customer base across 80 countries Over 20 products are commercialized with 8 prod
INR 546.5
evaluation 2 DMF filed and 1 CEP filed Capex of chemicals business underway at Barnala INR 546.5 Cr. Revenues INR 36.7 Cr. EBITDA 6.7 % EBITDA Margin INR 15.7 Cr. Profit After Tax 2.9
INR 36.7
d and 1 CEP filed Capex of chemicals business underway at Barnala INR 546.5 Cr. Revenues INR 36.7 Cr. EBITDA 6.7 % EBITDA Margin INR 15.7 Cr. Profit After Tax 2.9 % PAT Margin H1FY23 F
6.7 %
pex of chemicals business underway at Barnala INR 546.5 Cr. Revenues INR 36.7 Cr. EBITDA 6.7 % EBITDA Margin INR 15.7 Cr. Profit After Tax 2.9 % PAT Margin H1FY23 Financial Performance
INR 15.7
ss underway at Barnala INR 546.5 Cr. Revenues INR 36.7 Cr. EBITDA 6.7 % EBITDA Margin INR 15.7 Cr. Profit After Tax 2.9 % PAT Margin H1FY23 Financial Performance INR 1,116.6 Cr. Revenue
2.9 %
.5 Cr. Revenues INR 36.7 Cr. EBITDA 6.7 % EBITDA Margin INR 15.7 Cr. Profit After Tax 2.9 % PAT Margin H1FY23 Financial Performance INR 1,116.6 Cr. Revenues INR 97.9 Cr. EBITDA 8.
INR 1,116.6
BITDA Margin INR 15.7 Cr. Profit After Tax 2.9 % PAT Margin H1FY23 Financial Performance INR 1,116.6 Cr. Revenues INR 97.9 Cr. EBITDA 8.8 % EBITDA Margin INR 50.6 Cr. Profit After Tax 4.5
INR 97.9
Profit After Tax 2.9 % PAT Margin H1FY23 Financial Performance INR 1,116.6 Cr. Revenues INR 97.9 Cr. EBITDA 8.8 % EBITDA Margin INR 50.6 Cr. Profit After Tax 4.5 % PAT Margin 6 Segm
8.8 %
% PAT Margin H1FY23 Financial Performance INR 1,116.6 Cr. Revenues INR 97.9 Cr. EBITDA 8.8 % EBITDA Margin INR 50.6 Cr. Profit After Tax 4.5 % PAT Margin 6 Segmental highlights C
INR 50.6
Financial Performance INR 1,116.6 Cr. Revenues INR 97.9 Cr. EBITDA 8.8 % EBITDA Margin INR 50.6 Cr. Profit After Tax 4.5 % PAT Margin 6 Segmental highlights Chemical Segment Operating